It was reported this past week that more than two-dozen drug manufacturers are planning to raise the list price of many of their products in early 2019. On the surface this seems to be a delayed ‘slap in the face’ at President Trump who has made lowering the cost of drugs a primary objective. Many of these same manufacturers had announced back in mid-2018 that they had intended to raise prices; however, following public shaming from the White House later relented, stating that they would delay those rate hikes until 2019, and now it appears that those chickens have come home to roost.
Read More
Topics:
Cure for Healthcare,
prescription drugs,
Trump
The past Friday, on the eve of the last day of the 2019 Open Enrollment season for the ACA’s Federal Marketplace, Americans have found themselves, yet again, at another legal crossroads concerning health care in the United States. According to a ruling issued by U.S. District Judge Reed O’Connor, due to the elimination of the penalty surrounding the Individual Mandate as a result of the Tax Cuts and Jobs Act of 2017, the Affordable Care Act is unconstitutional. While the fall out of this decision has yet to be determined and for the time being, both Health and Human Services along with the White House have stated no immediate changes will occur as a result of this ruling, appeals have already begun and as such, the ACA will once again end up in the Supreme Court.
Read More
Topics:
ACA,
Obamacare,
SCOTUS,
Supreme Court
As we near the end of this, the 6th Open Enrollment period since the ACA was implemented; all indicators are that the overall enrollment numbers are down. While it is easy to point to the most common reasons we might hear is the cause, a deeper dive into all factors surrounding enrollment is essential to understanding all of the various drivers of the dismal enrollment numbers.
Read More
Topics:
ACA,
Obamacare,
Health Insurance,
healthcare reform
The things that we do impact our lives. The foods we eat, how much sleep we get, exercise (or lack thereof), even what we watch on TV can have an impact on our health (both physical and mental). This isn’t news to us as most rational people recognize the correlation between our actions and our health, but what if our health insurance companies new all these details about us? Would we change our behavior if it impacted our ability to be insured or increased our health insurance rates? Or, would we simply try hiding these specific details of our life so that those that could use this information against us wouldn’t have access to it?
Read More
Topics:
U.S. Healthcare,
Health Insurance,
data,
Social Media
Late last week, The Council of Economic Advisers which operates within the Executive Office of the President released a nearly 30 page white paper outlining issues related to the ongoing increase in costs associate
d with pharmaceutical drugs. The report was broken into multiple parts, ranging from introducing this issue, describing how Americans are paying higher prices for prescription drugs than the rest of the developed world, and finally how we might improve innovation to reduce the overall price of healthcare. Within the sub-parts of the document were topics including how Medicaid and Medicare procure prescriptions for their participants, how other world markets are benefiting from the U.S. led innovation and development, how middle-men known as Prescription Benefit Managers are inflating the overall cost of prescriptions, and the lengthy process by which drugs become available in the marketplace.
SUMMARY & COMMENTARY
While the original intent of the White Paper was to both outline problems and offer up solutions, the document favored the former, and provided little by way of real policies that might impact the rising cost of prescription drugs. We agree with the information provided in the brief; however it fell short in the areas of solutions only offering few suggestions limited in substance. Healthcare is a real problem in the United States making up 18% of the Gross Domestic Product. Of the $3.4 trillion spent on healthcare each year in the United States, roughly 20% of that number, $457 billion, is on prescription drugs. Said differently, for every $100 generated in the United States, $2.50 is spent on prescriptions.
Read More
Topics:
Republican Healthcare,
healthcare reform,
iamthelorax,
prescription drugs
Seth Denson joins "Need to Know with Jeff Angelo" on 1040 WHO in Des Moines to discuss the Amazon, Berkshire Hathaway, JP Morgan collaboration on healthcare and its impact on the stock market.
Read More
Topics:
healthcare reform,
stock market,
iowa,
amazon,
iamthelorax
Seth Denson join's Brian Glenn on DFW's KEXB Radio to discuss all things Healthcare, Amazon and living in North Texas.
Read More
Topics:
healthcare,
amazon,
texas,
iamthelorax
GDP Co-Founder, Seth Denson is interviewed by Fox News anchor Jessica Rosenthal regarding Amazon, Berkshire Hathaway & JP Morgans recent annoucment that they will collaborate impact the healthcare of their employees.
Read More
Topics:
healthcare,
amazon
Today, both the House of Representatives and the U.S. Senate are expected to pass the “Tax Cuts and Jobs Act” (recently re-named due to Senate rules related to the length of the name of the bill). While all of the details related to the new legislation will become clearer over time, one key provision that is catching quite a bit of attention (including ours) is the provision impacting the individual mandate that ALL citizens be covered by a qualified health insurance plan.
Read More
Topics:
ACA,
Individual Mandate,
Tax Reform
In the early hours of the morning, the U.S. Senate voted down the "Skinny Repeal" - here are our thoughts on that vote, as well as the future of healthcare reform in the United States.
Read More
Topics:
ACA,
Cure for Healthcare,
Skinny Repeal,
BCRA